News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
67 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17605)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4667)
June (3468)
July (2307)
August (2524)
September (2745)
October (3357)
November (3389)
December (2298)
Day
1 (197)
2 (226)
3 (194)
4 (181)
5 (115)
6 (9)
7 (20)
8 (215)
9 (188)
10 (146)
11 (166)
12 (67)
13 (1)
14 (1)
15 (134)
16 (171)
17 (154)
18 (157)
19 (63)
20 (1)
21 (2)
22 (171)
23 (167)
24 (223)
25 (185)
26 (71)
27 (1)
28 (3)
29 (192)
30 (239)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Business
Strategic Collaboration between Adaptimmune and Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies Terminated
Company remains focused on launching afami-cel later this year with a PDUFA date of August 4th and developing its broader sarcoma franchise
April 12, 2024
·
2 min read
Sona Nanotech Provides Interim Results of Dalhousie Efficacy Study
Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the “Company” or “Sona”) is pleased to announce further positive interim results from its study
April 12, 2024
·
5 min read
U.S. Gene Therapy Market Size, Share & Growth Report, 2033
According to Nova One Advisor, the U.S. gene therapy market size was valued at USD 3.19 billion in 2023
April 12, 2024
·
15 min read
U.S. Biotechnology Market Size to Increase USD 1.79 Trillion by 2033
According to Nova One Advisor, the U.S. Biotechnology market size was estimated at USD 552.49 billion in 2023
April 12, 2024
·
13 min read
Rapid Microbiology Testing Market Size is Expanding to USD 12.37 Billion by 2033
The global rapid microbiology testing market was valued at 5.2 billion in 2022 and is anticipated to reach around 12.37 billion by 2032, expanding at a CAGR of 9.1% from 2023 to 2032.
April 12, 2024
·
9 min read
Orpyx to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Orpyx, a med tech + touch company dedicated to transforming diabetic limb management, is pleased to announce that Dr. Breanne Everett, Founder and CEO
April 12, 2024
·
2 min read
DMSO Cell Cryopreservation Medium Market Expected to Expand with a CAGR of 9.11% from 2024-2031
Global DMSO Cell Cryopreservation Medium Market is expected to expand with a CAGR of 9.11% during the forecast period of 2024-2031.
April 12, 2024
·
4 min read
Business
Modalis Announces Partnership with Ginkgo Bioworks
Modalis Therapeutics Corporation announced that it has entered into an agreement with Ginkgo Bioworks to join the Ginkgo Technology Network.
April 12, 2024
·
3 min read
Vicore to Present at Upcoming April 2024 Investor Conferences
Vicore Pharma Holding AB, unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists, announced participation in the following investor conferences.
April 12, 2024
·
1 min read
Business
Invivyd Announces CEO TransitionJeremy Gowler appointed Interim CEO
Invivyd, Inc. today announced that the company’s Board of Directors has appointed Jeremy Gowler as Interim Chief Executive Officer (CEO), effective immediately, while the Board institutes a search for a permanent CEO.
April 12, 2024
·
9 min read
Previous
6 of 7
Next